Friday, December 19, 2025
ADVT 
International

WHO: Monkeypox won't turn into pandemic, but many unknowns

Darpan News Desk The Canadian Press, 30 May, 2022 10:01 AM
  • WHO: Monkeypox won't turn into pandemic, but many unknowns

LONDON (AP) — The World Health Organization’s top monkeypox expert said she doesn’t expect the hundreds of cases reported to date to turn into another pandemic, but acknowledged there are still many unknowns about the disease, including how exactly it’s spreading and whether the suspension of mass smallpox immunization decades ago may somehow be speeding its transmission.

In a public session on Monday, WHO's Dr. Rosamund Lewis said it was critical to emphasize that the vast majority of cases being seen in dozens of countries globally are in gay, bisexual or men who have sex with men, so that scientists can further study the issue and for those at risk to be careful.

“It’s very important to describe this because it appears to be an increase in a mode of transmission that may have been under-recognized in the past,” said Lewis, WHO's technical lead on monkeypox .

“At the moment, we are not concerned about a global pandemic,” she said. “We are concerned that individuals may acquire this infection through high-risk exposure if they don’t have the information they need to protect themselves.”

She warned that anyone is at potential risk of the disease, regardless of their sexual orientation. Other experts have pointed out that it may be accidental that the disease was first picked up in gay and bisexual men, saying it could quickly spill over into other groups if it is not curbed. To date, WHO said 23 countries that haven't previously had monkeypox have now reported more than 250 cases.

Lewis said it’s unknown whether monkeypox is being transmitted by sex or just the close contact between people engaging in sexual activity and described the threat to the general population as “low.” Monkeypox is known to spread when there is close physical contact with an infected person or their clothing or bedsheets.

She also warned that among the current cases, there is a higher proportion of people with fewer lesions that are more concentrated in the genital region and sometimes nearly impossible to see.

“You may have these lesions for two to four weeks (and) they may not be visible to others, but you may still be infectious," she said.

Last week, a top adviser to WHO said the outbreak in Europe, U.S., Israel, Australia and beyond was likely linked to sex at two recent raves in Spain and Belgium. That marks a significant departure from the disease’s typical pattern of spread in central and western Africa , where people are mainly infected by animals like wild rodents and primates, and epidemics haven’t crossed borders.

Scientists haven't yet determined whether the monkeypox outbreak in rich countries can be traced to Africa, but the disease continues to sicken people on the continent. On Monday, Nigerian authorities confirmed its first monkeypox death this year, in addition to six more cases. WHO says there are typically thousands of cases reported from Nigeria and Congo every year.

Most monkeypox patients experience only fever, body aches, chills and fatigue. People with more serious illness may develop a rash and lesions on the face and hands that can spread to other parts of the body. No deaths have been reported in the current outbreak beyond Africa.

WHO's Lewis also said that while previous cases of monkeypox in central and western Africa have been relatively contained, it was not clear if people could spread monkeypox without symptoms or if the disease might be airborne, like measles or COVID-19.

Monkeypox is related to smallpox, but has milder symptoms. After smallpox was declared eradicated in 1980, countries suspended their mass immunization programs, a move that some experts believe may be helping monkeypox spread, since there is now little widespread immunity to related diseases; smallpox vaccines are also protective against monkeypox.

Lewis said it would be “unfortunate” if monkeypox were able to “exploit the immunity gap” left by smallpox 40 years ago, saying that there was still a window of opportunity to close down the outbreak so that monkeypox would not become entrenched in new regions.

MORE International ARTICLES

Attacks on older Asians stoke fear as Lunar New Year begins

Attacks on older Asians stoke fear as Lunar New Year begins
City officials also have visited Chinatowns in San Francisco and Oakland this week to address residents' safety concerns and condemn the violence.

Attacks on older Asians stoke fear as Lunar New Year begins

UN: 'Concerning news' vaccines may not work against variants

UN: 'Concerning news' vaccines may not work against variants
Tedros added that WHO expected to make a decision “in the next few days” on whether it would recommend an emergency use listing for the AstraZeneca vaccine.

UN: 'Concerning news' vaccines may not work against variants

Britain to test mixing and matching of COVID-19 vaccines

Britain to test mixing and matching of COVID-19 vaccines
The vaccines being rolled out now require two doses, and people are supposed to get two shots of the same kind, weeks apart.

Britain to test mixing and matching of COVID-19 vaccines

In U.S., Europe, hope about future health crises

In U.S., Europe, hope about future health crises
The Pew Research Center poll out today finds optimism for the future among a majority of 4,000 respondents in the U.S., the United Kingdom, France and Germany.

In U.S., Europe, hope about future health crises

Don't sell single-shot vaccine short, Fauci says

Don't sell single-shot vaccine short, Fauci says
Dr. Anthony Fauci says Johnson and Johnson's vaccine has virtues beyond an efficacy rate that lags that of its predecessors.

Don't sell single-shot vaccine short, Fauci says

A look at COVID-19 vaccines already in use, or getting close

A look at COVID-19 vaccines already in use, or getting close
AstraZeneca: Developed with Oxford University; authorized by more than 40 countries, including Britain, India, Argentina, Mexico and the European Union.

A look at COVID-19 vaccines already in use, or getting close